Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
4D-150 reduces annualized anti-VEGF injection rate in wet AMD at 24 weeks
One intravitreal injection of 4D-150 helped reduce the mean annualized anti-VEGF injection rate in patients with wet age-related macular degeneration, according to a study presented at the American Society of Retina Specialists meeting.
VIDEO: ONL1204 slows geographic atrophy lesion growth in phase 1b study
In this Healio Video Perspective from the ASRS meeting, Durga Borkar, MD, of Duke University Eye Center presents data from a phase 1b study investigating ONL1204, a Fas inhibitor, for geographic atrophy.
Log in or Sign up for Free to view tailored content for your specialty!
Safety, efficacy consistent in Luxturna post-authorization study
Interim safety data from a post-authorization study of Luxturna in patients with genetic retinal diseases were consistent with clinical trial data, according to a presentation at the American Society of Retina Specialists annual meeting.
AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD
Taking a daily supplement with antioxidant vitamins and minerals may slow the progression of late-stage dry age-related macular degeneration and could help maintain central vision in affected patients, according to researchers at NIH.
VIDEO: Port delivery system maintains improvements in diabetic retinopathy at 2 years
In this Healio Video Perspective from the ASRS meeting, Margaret Chang, MD, MS, of Retinal Consultants Medical Group presents 2-year results for the port delivery system with ranibizumab.
VIDEO: Good phase 2 results reported for gene therapy in wet AMD at 26 weeks
In this Healio Video Perspective from the ASRS meeting, Laurent Fischer, MD, of Adverum Biotechnologies discusses 26-week results from the phase 2 LUNA study investigating Ixo-vec for neovascular age-related macular degeneration.
Investigational compound shows promise in treatment of diabetic macular ischemia
PARK CITY, Utah — Outcomes from the phase 1/2a HORNBILL study indicate a potential disease-modifying effect of BI 764524 in eyes with diabetic macular ischemia.
VIDEO: Extension study shows long-term efficacy, safety of faricimab in DME
In this Healio Video Perspective from the ASRS meeting, Arshad M. Khanani, MD, MA, FASRS, discusses the just-released 4-year efficacy and safety outcomes of faricimab in diabetic macular edema.
Clinical Trials at the Summit: Healio’s latest videos
Need to catch up on anything from this year’s Clinical Trials at the Summit? Here are some of Healio’s latest videos from the meeting.
VIDEO: Port delivery system shows real-world efficacy, safety in neovascular AMD
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, discusses efficacy and safety data for the port delivery system ahead of its reintroduction.